Interestingly, co-injection of tumor cells with IL-1R1−/− EGCs resulted in lower tumor growth and reduced infiltration of SPP1+ TAMs when compared with tumors co-injected with WT EGCs (Fig. 6f-g). Here, SPP1 is linked to neoplasm.